Sage Journals: Discover world-class research

Abstract

Background:

Currently, no consensus approach exists for optimal venous thromboembolism (VTE) prophylaxis in obese (BMI ≥30 kg/m²) patients. Time to development of in-hospital VTE is not well studied.

Objective:

This study evaluates time to in-hospital VTE in obese patients.

Methods:

A single-center, retrospective study evaluated obese patients that developed an in-hospital VTE. Patients were categorized into 3 BMI groups: 30 to 34.9 (group 1), 35 to 39.9 (group 2), and ≥40 (group 3) kg/m². The primary end point compared time to VTE between the groups.

Results:

A total of 246 patients were included, and time to VTE was similar between the groups, 8 (group 1) versus 8 (group 2) versus 9 days (group 3); P = .38. Secondary outcomes showed time to VTE was shorter in acute care versus ICU patients (7.5 vs 10 days; P = .01), nonsurgical versus surgical patients (6 vs 9 days; P = .004), and no prophylaxis versus mechanical plus pharmacologic prophylaxis (4.5 vs 9 days; P < .001).

Conclusions:

BMI category did not significantly impact time to in-hospital VTE. This study provides insight into the timing of in-hospital VTE in obese patients. The differences in prophylactic strategies highlight the importance of optimized prophylaxis.

Keywords

venous thromboembolism obese anticoagulation deep vein thrombosis prophylaxis

Get full access to this article

View all access options for this article.

References

Khanna

Maynard

Sadeghi

, et al. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers. J Hosp Med. 2014;9(4):221–225.

Maynard

. Preventing Hospital-Associated Venous Thromboembolism: A Guide for Effective Quality Improvement. 2nd ed. Rockville, MD: Agency for Healthcare Research and Quality; 2015. AHRQ Publication No. 16-0001-EF.

Cohen

Tapson

Bergmann

, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet. 2008;371(9610):387–394.

Beckman

Hooper

Critchley

, et al. Venous Thromboembolism. Am J Prev Med. 2010;38(4):S495–S501.

Raskob

Silverstein

Bratzler

, et al. Surveillance for deep vein thrombosis and pulmonary embolism. Am J Prev Med. 2010;38(4):S502–S509.

Anderson

. Risk factors for venous thromboembolism. Circulation. 2003;107(90231):I9–I16.

Kabrhel

Varraso

Goldhaber

, et al. Prospective study of BMI and the risk of pulmonary embolism in women. Obesity. 2009;17(11):2040–2046.

Eichinger

. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008;168(15):1678.

Oren

Smith

Doggen

, et al. Body mass index and the risk of venous thrombosis among postmenopausal women. J Thromb Haemost. 2006;4(10):2273–2275.

10.

Parkin

Sweetland

Balkwill

, et al. Body mass index, surgery, and risk of venous thromboembolism in middle-aged women: a cohort study. Circulation. 2012;125(15):1897–1904.

11.

Rathbun

. The surgeon general’s call to action to prevent deep vein thrombosis and pulmonary embolism. Circulation. 2009;119(15):e480–e482.

12.

Streiff

Brady

Grant

, et al. CDC Grand Rounds: Preventing Hospital-Associated Venous Thromboembolism. Cdcgov. 2014. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6309a3.htm. Accessed July 6, 2017.

13.

Kahn

Morrison

Cohen

, et al. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism. Cochrane Database Syst Rev. 2013;(7):CD008201.

14.

Mitchell

Collen

Petteys

, et al. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients1. J Thromb Haemost. 2012;10(2):236–243.

15.

Kahn

Lim

Dunn

, et al. Prevention of VTE in nonsurgical patients. Chest. 2012;141(2):e195S–e226S.

16.

Gould

Garcia

Wren

, et al. Prevention of VTE in nonorthopedic surgical patients. Chest. 2012;141(2):e227S–e277S.

17.

Falck-Ytter

Francis

Johanson

, et al. Prevention of VTE in orthopedic surgery patients. Chest. 2012;141(2):e278S–e325S.

18.

Venous Thromboembolism (DVT & PE) | NCBDDD | CDC. Venous Thromboembolism (DVT & PE) | NCBDDD | CDC. 2016. Accessed July 6, 2017. https://www.cdc.gov/ncbddd/dvt/ha-vte.html.

19.

McClendon

Smith

O’Shaughnessy

, et al. Time to event analysis for the development of venous thromboembolism after spinal fusion ≥5 levels. World Neurosurg. 2015;84(3):826–833.

20.

Length of Hospital Stay—Health Care Use—OECD iLibrary. Oecd-ilibraryorg. 2017. Accessed July 6, 2017. http://www.oecd-ilibrary.org/social-issues-migration-health/length-of-hospital-stay/indicator/english_8dda6b7a-en.

21.

Adriance

Murphy

. Prophylaxis and treatment of venous thromboembolism in the critically ill. Int J Crit Illn Inj Sci. 2013;3(2):143–151.

22.

Yang

Staercke

Hooper

. The effects of obesity on venous thromboembolism: a review. Open J Prev Med. 2012;2(4):499–509.

23.

Wang

Milligan

Wong

, et al. Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemostasis. 2013;111(1):88–93.

24.

Joy

Tharp

Hartman

, et al. Safety and efficacy of high-dose unfractionated heparin for prevention of venous thromboembolism in overweight and obese patients. Pharmacotherapy. 2016;36(7):740–748.

25.

Scholten

Hoedema

Scholten

. A comparison of two different prophylactic dose regimens of low molecular weight heparin in bariatric surgery. Obes Surg. 2002;12(1):19–24.

26.

Escalante-Tattersfield

Tucker

Fajnwaks

, et al. Incidence of deep vein thrombosis in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2008;4(2):126–130.

Evaluating Time to In-Hospital Venous Thromboembolism in Obese Patients